Search Results - Mei Elsayed

  • Showing 1 - 3 results of 3
Refine Results
  1. 1
    Therapeutic Sequencing in ALK+ NSCLC

    Therapeutic Sequencing in ALK+ NSCLC by Mei Elsayed, Petros Christopoulos

    Published 2021
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  2. 2
    <i>EML4‐ALK</i> fusion variant V3 is a high‐risk feature conferring accelerated metastatic spread, early treatment failure and worse overall survival in ALK<sup>+</sup> non‐small cell lung cancer

    <i>EML4‐ALK</i> fusion variant V3 is a high‐risk feature conferring accelerated metastatic spread, early treatment failure and worse overall survival in ALK<sup>+</sup> non‐small c... by Petros Christopoulos, Volker Endris, Farastuk Bozorgmehr, Mei Elsayed, Martina Kirchner, Jonas Ristau, Ivo Buchhalter, Roland Penzel, Felix J.F. Herth, Claus Peter Heußel, Martin Eichhorn, Thomas Muley, Michael Meister, Jürgen R. Fischer, Stefan Rieken, Arne Warth, Helge Bischoff, Peter Schirmacher, Albrecht Stenzinger, Michael Thomas

    Published 2018
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    Identification of a highly lethal V3<sup>+</sup>TP53<sup>+</sup> subset in ALK<sup>+</sup> lung adenocarcinoma

    Identification of a highly lethal V3<sup>+</sup>TP53<sup>+</sup> subset in ALK<sup>+</sup> lung adenocarcinoma by Petros Christopoulos, Martina Kirchner, Farastuk Bozorgmehr, Volker Endris, Mei Elsayed, Jan Budczies, Jonas Ristau, Roland Penzel, Felix J.F. Herth, Claus Peter Heußel, Martin Eichhorn, Thomas Muley, Michael Meister, Jürgen R. Fischer, Stefan Rieken, Felix Lasitschka, Helge Bischoff, Rocı́o Sotillo, Peter Schirmacher, Michael Thomas, Albrecht Stenzinger

    Published 2018
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: